Articles published by Samsung Bioepis![]()
Samsung Bioepis Secures US License Date for SB17, a Proposed Biosimilar to Stelara®
November 30, 2023
From Samsung Bioepis
Via GlobeNewswire
![]() ![]() ![]() ![]()
Samsung Bioepis Partners with Sandoz to Commercialize Ustekinumab Biosimilar Candidate
September 11, 2023
From Samsung Bioepis
Via GlobeNewswire
![]()
Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar
August 01, 2023
From Samsung Bioepis
Via GlobeNewswire
Tickers
OGN
![]() From Samsung Bioepis
Via GlobeNewswire
![]()
Samsung Bioepis Releases 2023 Sustainability Report
June 30, 2023
From Samsung Bioepis
Via GlobeNewswire
![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|